clarification to my prior post (#6669901) after reading back over the quarterly activities statement:
In my post above, the suggested $/lb figures were based on the "resource estimate" which states:
Indicated resources, zones 1&2 = 257Mlb
Inferred resources, zones 1,2,3&4 = 110Mlb
By comparison, the DFS "Reserve Estimate" states:
Probable Reserves are as follows:
zone 1 = 102.2Mlb
zone 2 = 122.5Mlb
total = 224.8Mlb
If we use the reserve estimate rather than the resource, the reserve is about 87.47% of the resource; so the $/lb paid for the U308 would be higher (about 14.3%) than those I have quoted.
The reason for posting this clarification is that many have commented on / compared the $/lb paid for Mantra resources. I have not yet researched Mantra to assess the basis of the figures quoted in relation to that transaction, but thought it is important to clarify my figures for those drawing this comparison to ensure we are comparing apples with apples.
Will post more later when time permits - back to work for now.
- Forums
- ASX - By Stock
- 270p kah bid = ~ext $9.32p/s
clarification to my prior post (#6669901) after reading back...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EXT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.08M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.9¢ | $52.96K | 5.716M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 708194 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 7745064 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 708194 | 0.009 |
10 | 6523057 | 0.008 |
10 | 4306019 | 0.007 |
5 | 1618942 | 0.006 |
3 | 5500000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 7745064 | 14 |
0.011 | 5248150 | 6 |
0.012 | 5938361 | 5 |
0.013 | 10099423 | 3 |
0.014 | 15131428 | 3 |
Last trade - 15.57pm 15/07/2024 (20 minute delay) ? |
Featured News
EXT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online